Needham & Company
-
Companies with NDRs 10/22
-
Nabriva Therapeutics AG (NBRV) PT Lowered to $10 at Needham & Company
-
Nabriva Therapeutics to Present at the Needham and Company 18th Annual Healthcare Conference
-
Nabriva Therapeutics AG (NBRV) PT Lowered to $15 at Needham & Company
-
Nabriva (NBRV) Prices 18.18M Share Common Offering at $2.75/Sh
-
Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million
-
Pre-Open Movers 05/22: (PLAB) (ACIA) (AAP) Higher; (LBY) (DY) (JCP) Lower (more...)
-
Nabriva Therapeutics to Present at the Needham and Company 17th Annual Healthcare Conference
-
Nabriva (NBRV) Prices 9.41M Common Share Offering at $8.50/Sh
-
Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million
-
Nabriva (NBRV) Commences $80M Public Offering of Ordinary Shares
-
Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares
-
Nabriva Therapeutics AG (NBRV) PT Raised to $18 at Needham & Company
-
Nabriva Therapeutics to Present at the Needham and Company 16th Annual Healthcare Conference
-
Nabriva Therapeutics AG to Present at the 15th Annual Needham Healthcare Conference
-
Needham & Company Starts Nabriva Therapeutics AG (NBRV) at Buy
-
Nabriva Therapeutics Announces Exercise of Over-Allotment Option
-
Nabriva Therapeutics Announces Closing of Its Initial Public Offering
-
Nabriva Therapeutics AG (NBRV) IPO Opens Up 8%
-
Nabriva Therapeutics AG (NBRV) IPO Prices at $10.25/ADS, Slightly Below Expectations
-
Nabriva Therapeutics Prices Initial Public Offering
-
Nabriva Therapeutics (NBRV) Files $92M IPO

